Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Success and complication rates of two precut techniques, transpancreatic sphincterotomy and needle-knife sphincterotomy for bile duct cannulation.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2010
Same author

Effect of Medicaid coverage of tobacco-dependence treatments on smoking cessation.

International journal of environmental research and public health·2010
Same author

Cytokine and autoantibody patterns in acute liver failure.

Journal of immunotoxicology·2009
Same author

A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice.

BMC gastroenterology·2009
Same author

Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients' prognosis.

The Journal of surgical research·2009
Same author

Estrogen receptor neurobiology and its potential for translation into broad spectrum therapeutics for CNS disorders.

Current molecular pharmacology·2009

Related Experiment Video

Updated: Jul 4, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

[Hepatitis B surface antigen terminates codon bias selection].

Jun Qiang Li1, Jing Hua Tian, Feng Liu

  • 1Hepatology Institute, Peking University People's Hospital, Beijing, China.

Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences
|June 19, 2008
PubMed
Summary

Hepatitis B surface antigen (HBsAg) termination codon bias exists, with TAA being more common than TGA. This bias may influence RNA structure and protein function during evolution.

More Related Videos

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Related Experiment Videos

Last Updated: Jul 4, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Area of Science:

  • Molecular Biology
  • Virology
  • Genetics

Context:

  • Hepatitis B virus (HBV) infection is a global health concern.
  • Understanding HBV genetic variations is crucial for therapeutic strategies.
  • Termination codon usage in viral genes can impact protein expression and function.

Purpose:

  • To investigate the existence and conditions of termination codon bias in the hepatitis B surface antigen (HBsAg) gene.
  • To analyze the relationship between HBsAg termination codon usage, RNA secondary structure, and protein sequence.

Summary:

  • Analysis of 174 HBV reference sequences revealed two types of HBsAg termination codons: TAA (71.26%) and TGA (28.74%).
  • Evidence of codon bias selection was observed at the HBsAg termination codon.
  • This bias was found to influence RNA secondary structure and the amino acid sequence encoding the HBsAg protein.

Impact:

  • The findings suggest that HBsAg termination codon bias is a real phenomenon.
  • This bias may play a role in maintaining RNA structure and conserving protein function during HBV evolution.
  • Further research could explore the implications of this bias for HBV pathogenesis and treatment.